{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:52:06Z","timestamp":1768809126970,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA12777"],"award-info":[{"award-number":["R01DA12777"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA15020"],"award-info":[{"award-number":["R01DA15020"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA25524"],"award-info":[{"award-number":["R01DA25524"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA040325"],"award-info":[{"award-number":["U01DA040325"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA048780"],"award-info":[{"award-number":["R21DA048780"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00330-021-07755-7","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T17:06:29Z","timestamp":1614791189000},"page":"2756-2767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular risk factors and illicit drug use may have a more profound effect on coronary atherosclerosis progression in people living with HIV"],"prefix":"10.1007","volume":"31","author":[{"given":"M\u00e1rton","family":"Kolossv\u00e1ry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot K.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Gerstenblith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Bluemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul N.","family":"Mandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Celentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Kickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bazr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-9609","authenticated-orcid":false,"given":"Shenghan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"7755_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G Hutter","year":"2009","unstructured":"Hutter G, Nowak D, Mossner M et al (2009) Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N Engl J Med 360:692\u2013698","journal-title":"N Engl J Med"},{"key":"7755_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"RK Gupta","year":"2019","unstructured":"Gupta RK, Abdul-Jawad S, McCoy LE et al (2019) HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation. Nature 568:244\u2013248","journal-title":"Nature"},{"key":"7755_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","volume":"73","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Chao CR, Leyden WA et al (2016) Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr 73:39\u201346","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7755_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0000000000000960","volume":"72","author":"AE Siddiqi","year":"2016","unstructured":"Siddiqi AE, Hall HI, Hu X, Song R (2016) Population-based estimates of life expectancy after HIV diagnosis: United States 2008-2011. J Acquir Immune Defic Syndr 72:230\u2013236","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7755_CR5","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"C Antiretroviral Therapy Cohort","year":"2017","unstructured":"Antiretroviral Therapy Cohort C (2017) Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4:e349\u2013e356","journal-title":"Lancet HIV"},{"key":"7755_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11883-017-0651-4","volume":"19","author":"JC Lacson","year":"2017","unstructured":"Lacson JC, Barnes RP, Bahrami H (2017) Coronary artery disease in HIV-infected patients: downside of living longer. Curr Atheroscler Rep 19:18","journal-title":"Curr Atheroscler Rep"},{"key":"7755_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7326\/M13-1754","volume":"160","author":"WS Post","year":"2014","unstructured":"Post WS, Budoff M, Kingsley L et al (2014) Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med 160:458\u2013467","journal-title":"Ann Intern Med"},{"key":"7755_CR8","doi-asserted-by":"crossref","unstructured":"Bahrami H, Budoff M, Haberlen SA et al (2016) Inflammatory markers associated with subclinical coronary artery disease: the Multicenter AIDS Cohort Study. J Am Heart Assoc 5(6):e003371","DOI":"10.1161\/JAHA.116.003371"},{"key":"7755_CR9","doi-asserted-by":"publisher","first-page":"e002529","DOI":"10.1161\/JAHA.115.002529","volume":"5","author":"H Lai","year":"2016","unstructured":"Lai H, Moore R, Celentano DD et al (2016) HIV infection itself may not be associated with subclinical coronary artery disease among African Americans without cardiovascular symptoms. J Am Heart Assoc 5:e002529","journal-title":"J Am Heart Assoc"},{"key":"7755_CR10","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehy163","volume":"39","author":"PE Tarr","year":"2018","unstructured":"Tarr PE, Ledergerber B, Calmy A et al (2018) Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons. Eur Heart J 39:2147\u20132154","journal-title":"Eur Heart J"},{"key":"7755_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","volume":"16","author":"PY Hsue","year":"2019","unstructured":"Hsue PY, Waters DD (2019) HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol 16:745\u2013759","journal-title":"Nat Rev Cardiol"},{"key":"7755_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.2017172181","volume":"287","author":"MT Lu","year":"2018","unstructured":"Lu MT, Meyersohn NM, Mayrhofer T et al (2018) Central core laboratory versus site interpretation of coronary CT angiography: agreement and association with cardiovascular events in the PROMISE Trial. Radiology 287:87\u201395","journal-title":"Radiology"},{"key":"7755_CR13","unstructured":"Centers for Disease Control and Prevention (2020) Estimated HIV incidence and prevalence in the United States, 2014\u20132018. HIV Surveillance Supplemental Report 25(1). http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed 2020.08.01"},{"key":"7755_CR14","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","volume":"71","author":"HJ Chang","year":"2018","unstructured":"Chang HJ, Lin FY, Lee SE et al (2018) Coronary atherosclerotic precursors of acute coronary syndromes. J Am Coll Cardiol 71:2511\u20132522","journal-title":"J Am Coll Cardiol"},{"key":"7755_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jcct.2018.01.002","volume":"12","author":"S Deseive","year":"2018","unstructured":"Deseive S, Straub R, Kupke M et al (2018) Quantification of coronary low-attenuation plaque volume for long-term prediction of cardiac events and reclassification of patients. J Cardiovasc Comput Tomogr 12:118\u2013124","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"7755_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1086\/526782","volume":"46","author":"S Lai","year":"2008","unstructured":"Lai S, Fishman EK, Lai H et al (2008) Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms. Clin Infect Dis 46:600\u2013610","journal-title":"Clin Infect Dis"},{"key":"7755_CR17","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","volume":"74","author":"A Ahmadi","year":"2019","unstructured":"Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J (2019) From subclinical atherosclerosis to plaque progression and acute coronary events: JACC State-of-the-Art Review. J Am Coll Cardiol 74:1608\u20131617","journal-title":"J Am Coll Cardiol"},{"key":"7755_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805971","volume":"379","author":"S-H Investigators","year":"2018","unstructured":"Investigators S-H, Newby DE, Adamson PD et al (2018) Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 379:924\u2013933","journal-title":"N Engl J Med"},{"key":"7755_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcmg.2010.04.011","volume":"3","author":"K Inoue","year":"2010","unstructured":"Inoue K, Motoyama S, Sarai M et al (2010) Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 3:691\u2013698","journal-title":"JACC Cardiovasc Imaging"},{"key":"7755_CR20","volume-title":"Linear mixed models for longitudinal data","author":"G Verbeke","year":"2000","unstructured":"Verbeke G, Molenberghs G (2000) Linear mixed models for longitudinal data. Springer, New York"},{"key":"7755_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCULATIONAHA.105.545459","volume":"112","author":"JL Fleg","year":"2005","unstructured":"Fleg JL, Morrell CH, Bos AG et al (2005) Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation 112:674\u2013682","journal-title":"Circulation"},{"key":"7755_CR22","unstructured":"R Core Team (2017) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.\u00a0https:\/\/www.R-project.org\/. Accessed\u00a02020.08.01"},{"key":"7755_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ahj.2018.12.016","volume":"212","author":"SK Grinspoon","year":"2019","unstructured":"Grinspoon SK, Fitch KV, Overton ET et al (2019) Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J 212:23\u201335","journal-title":"Am Heart J"},{"key":"7755_CR24","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","volume":"2","author":"J Lo","year":"2015","unstructured":"Lo J, Lu MT, Ihenachor EJ et al (2015) Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV 2:e52\u2013e63","journal-title":"Lancet HIV"},{"key":"7755_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2019.02.011","volume":"212","author":"U Hoffmann","year":"2019","unstructured":"Hoffmann U, Lu MT, Olalere D et al (2019) Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers. Am Heart J 212:1\u201312","journal-title":"Am Heart J"},{"key":"7755_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2105\/AJPH.2012.301162","volume":"103","author":"MJ Mimiaga","year":"2013","unstructured":"Mimiaga MJ, Reisner SL, Grasso C et al (2013) Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health 103:1457\u20131467","journal-title":"Am J Public Health"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-07755-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T10:47:49Z","timestamp":1618310869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-07755-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["7755"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-07755-7","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Shenghan Lai.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Marton Kolossvary) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board at Johns Hopkins School of Medicine approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in JAHA (Lai H, Moore R, Celentano DD, et al. HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms. <i>J Am Heart Assoc<\/i>. 2016;5(3):e002529. Published 2016 Mar 24. doi:10.1161\/JAHA.115.002529).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 prospective\u2022 observational\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}